Key points are not available for this paper at this time.
Recent work reveals the need to re-examine the current paradigms for managing the potential identifiability of genomic and other "omic"-type data. Also see News story and Report by Gymrek et al.
Rodriguez et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: